EP3256479
4-setin bensoxabóról efnasambönd og notkun þeirra
:
EP einkaleyfi í gildi á Íslandi:
12.2.2016:
29.7.2020:
16706002.9
:
17.9.2020:
15.10.2020
:
11.2.2036:
11.2.2026:
28.2.2026
:
4 -SUBSTITUTED BENZOXABOROLE COMPOUNDS AND USES THEREOF
12.2.2016
29.7.2020
17.9.2020
15.10.2020
11.2.2026
:
GlaxoSmithKline Intellectual Property (No. 2) Limited:
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, GB
:
Anacor Pharmaceuticals, Inc.:
1020 East Meadow Circle, Palo Alto, CA 94303, US
:
ALEMPARTE-GALLARDO, Carlos:
28760 Tres Cantos (Madrid), ES
:
ALLEY, M.R.K. (dickon):
Palo Alto, California 94303, US
:
BARROS-AGUIRRE, David:
28760 Tres Cantos (Madrid), ES
:
GIORDANO, Ilaria:
28760 Tres Cantos (Madrid), ES
:
HERNANDEZ, Vincent:
Palo Alto, California 94303, US
:
LI, Xianfeng:
Palo Alto, California 94303, US
:
PLATTNER, Jacob J.:
Palo Alto, California 94303, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
15382054:
12.2.2015:
EP
:
15382055:
12.2.2015:
EP
:
15382056:
12.2.2015:
EP
:
IB2016050775:
12.2.2016
:
C07F 5/02, A61P 31/06, A61K 31/69
: 6
: 13.1.2021
: 11.2.2022
: Örn Þór slf.
: 7
: 19.1.2022
: 11.2.2023
: Patice ehf.
: 8
: 19.1.2023
: 11.2.2024
: Árnason Faktor ehf.
: 9
: 23.1.2024
: 11.2.2025
: Árnason Faktor ehf.
: 9
: 23.1.2024
: 11.2.2025
: Árnason Faktor ehf.
: 10
: 29.1.2025
: 11.2.2026
: Árnason Faktor ehf.